This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Oct 12;478(7368):S16-8.

doi: 10.1038/478S16a.

Translational research: The American way

PMID: 21993821
DOI: 10.1038/478S16a

Translational research: The American way

Amy Maxmen. Nature. 2011.

. 2011 Oct 12;478(7368):S16-8.

doi: 10.1038/478S16a.

Author

PMID: 21993821
DOI: 10.1038/478S16a

No abstract available

PubMed Disclaimer

Similar articles

Masterclass: The gathering brainstorm.
McGowan K. McGowan K. Nature. 2011 Oct 12;478(7368):S19-20. doi: 10.1038/478S19a. Nature. 2011. PMID: 21993822 No abstract available.
Cancer experts point to new advances in research and treatment: A recent report by the American Association for Cancer Research highlights unprecedented successes as well as ongoing challenges in the cancer field.
Printz C. Printz C. Cancer. 2019 Apr 15;125(8):1211-1213. doi: 10.1002/cncr.32087. Cancer. 2019. PMID: 30934127 No abstract available.
Bridging the gap between research and practice.
Braillon A. Braillon A. Am J Med. 2011 Nov;124(11):e15. doi: 10.1016/j.amjmed.2011.04.015. Am J Med. 2011. PMID: 21684514 No abstract available.
Assessing tumor-related signs and symptoms to support cancer drug approval.
Williams G, Pazdur R, Temple R. Williams G, et al. J Biopharm Stat. 2004 Feb;14(1):5-21. doi: 10.1081/BIP-120028503. J Biopharm Stat. 2004. PMID: 15027497 Review.
Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.
Browne TR. Browne TR. Epilepsy Res Suppl. 1993;10:31-44. Epilepsy Res Suppl. 1993. PMID: 8251105 Review. No abstract available.

See all similar articles

Cited by

Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.
Prajapati RN, Bhushan B, Singh K, Chopra H, Kumar S, Agrawal M, Pathak D, Chanchal DK, Laxmikant. Prajapati RN, et al. Curr Pharm Biotechnol. 2024;25(16):2060-2077. doi: 10.2174/0113892010275850240102105033. Curr Pharm Biotechnol. 2024. PMID: 38288793 Review.
Approaching the in vitro clinical trial: engineering organs on chips.
Capulli AK, Tian K, Mehandru N, Bukhta A, Choudhury SF, Suchyta M, Parker KK. Capulli AK, et al. Lab Chip. 2014 Sep 7;14(17):3181-6. doi: 10.1039/c4lc00276h. Lab Chip. 2014. PMID: 24828385 Free PMC article.
The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors.
Boghaert ER, Lu X, Hessler PE, McGonigal TP, Oleksijew A, Mitten MJ, Foster-Duke K, Hickson JA, Santo VE, Brito C, Uziel T, Vaidya KS. Boghaert ER, et al. Neoplasia. 2017 Sep;19(9):695-706. doi: 10.1016/j.neo.2017.06.004. Epub 2017 Aug 5. Neoplasia. 2017. PMID: 28787674 Free PMC article.
Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond.
Schork NJ, Nazor K. Schork NJ, et al. Adv Genet. 2017;97:81-113. doi: 10.1016/bs.adgen.2017.06.001. Epub 2017 Jul 25. Adv Genet. 2017. PMID: 28838357 Free PMC article. Review.
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu.
Singh M, Ferrara N. Singh M, et al. Nat Biotechnol. 2012 Jul 10;30(7):648-57. doi: 10.1038/nbt.2286. Nat Biotechnol. 2012. PMID: 22781694 Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group